Intended for healthcare professionals

Editorials

Inappropriate use of progression-free survival in cancer drug approvals

BMJ 2020; 368 doi: https://doi.org/10.1136/bmj.m770 (Published 10 March 2020) Cite this as: BMJ 2020;368:m770